Jonathan McBride, MD
Pain Medicine · Vonore, TNNPI 1962899526
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $11,715 with a category attached, or 85.4%. Boston Scientific accounts for 88.9% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $10,019 and has fallen 99.3% since, to $73 in 2025.
Across 64 payments — averaging $183.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Nevro Corp.$589
- Relievant Medsystems, Inc.$155
- Nalu Medical, Inc.$86
- Medtronic$64
- Innovation Technologies Inc$58
- plus $343 from 16 others
What the payments were for
- Grants$10,00085%
- Food & beverage$1,71515%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 14 | $10,421 |
| Nevro Corp. | 20 | $589 |
| Relievant Medsystems, Inc. | 2 | $155 |
| Nalu Medical, Inc. | 5 | $86 |
| Medtronic | 3 | $64 |
| Innovation Technologies Inc | 1 | $58 |
| Scilex Pharmaceuticals Inc. | 3 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Abbott | 2 | $28 |
| Trevena, Inc. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Stimwave Technologies Incorporated | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| AbbVie | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Stratus Medical, LLC | 1 | $18 |
| GRT US Holding, Inc. | 1 | $18 |
| Stryker | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| UCB, Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$10,000
- Intracept$518
- GENERAL - THERAPIES$164
- Senza$140
- Senza Spinal Cord Stimulation System$131
How this compares
$11,715 in reported general payments places this provider in the 80th percentile of 112 pain medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Potassium | 18 | $13,657 |
| Buprenorphine | 19 | $2,781 |
| Pregabalin | 61 | $1,186 |
| Lidocaine | 15 | $948 |
| Gabapentin | 82 | $729 |
| Methocarbamol | 90 | $573 |
| Baclofen | 75 | $468 |
| Cyclobenzaprine Hcl | 16 | $157 |
| Duloxetine Hcl | 19 | $133 |
| Meloxicam | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Vonore
- Shravani DurbhakulaNashville$353K
- Joseph DichiaraKnoxville$102K
- Stephanie VanterpoolKnoxville$69K
- Herbert MeltzerNashville$43K
- Marc HuntoonNashville$37K
- Gregory BallChattanooga$35K
- Phillip GreenMemphis$34K
- Puneet MishraNashville$32K
- John BlakeChattanooga$28K
- Andrew DudasMemphis$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.